Oncotherapy Revolution
By Isomer Organics
By Isomer Organics
ABOUT
Delivering a therapeutic drug for intractable cancer to society with L-glucose, which is highly selective for cancer cells.
We are a medical startup company founded in Kyoto in 2018 with the goal of bringing a therapeutic drug for intractable cancer to society. We are researching cancer treatment technologies and creating cancer diagnostic and therapeutic drugs so that we can help patients suffering from cancer as soon as possible.
CORPORATEMISSION
-
Leading patients with intractable cancer to a complete cure.
We aim to realize a new anti-cancer drug with L-glucose bound Orbio-molecules. We deliver the hope of complete cure beyond the diversity of intractable cancer.
-
Introducing a new treatment modality for cancer therapy.
We will implement “cancer-specific cell therapy” using L-glucose as a drug delivery system (DDS), which shows unprecedented high selectivity in cancer treatment.
VALUE
TEAM
-
Dr. EIICHI
YAMAGUCHI
CEOProfessor Emeritus, Kyoto University
Doctor of Science -
Dr. HIDEKI
IIJIMA
COODoctor of Engineering
Ph.D. in Management of Innovative Management -
Dr. KATSUYA
YAMADA
CMOORBIO-Chaired Professor, Department of Molecular Transport, Hirosaki University Graduate School of Medicine
Visiting Professor, Osaka Metropolitan University Graduate School of Medicine
Ph.D. in Medicine; Councilor of the Physiological Society of Japan -
KEI
YAMAGUCHI
CFOMaster of Commerce
-
Event
Dr. Yamada, CMO, Gave an Invited Lecture at Rare Sugar Congress 2023
-
Event
Dr. Yamaguchi, CEO, Pitched at Japan-UK Virtual Partnering Event
-
Event
CEO, Dr. Yamaguchi Pitching at Minerva Business Plan Presentation
-
News
We have renewed our website.
-
Technology
Requested Lecture: “Ascites fluid cytology using fluorescently labeled L-glucose compound 2-NBDLG”
This website uses cookies.Please agree to the acquisition and use of cookies based on the personal information protection policy.
ACCEPT